A Multi-arm, Phase 3, Randomized, Placebo Controlled, Double Blind Clinical Trial to Investigate the Efficacy and Safety of Fostemsavir (BMS-663068/GSK3684934) in Heavily Treatment Experienced Subjects Infected With Multi-drug Resistant HIV-1 (BRIGHTE Study)
A Multi-arm, Phase 3, Randomized, Placebo Controlled, Double Blind Clinical Trial to Investigate the Efficacy and Safety of Fostemsavir (BMS-663068/GSK3684934) in Heavily Treatment Experienced Subjects Infected With Multi-drug Resistant HIV-1 (BRIGHTE Study)
The purpose of this study is to determine whether the BMS Attachment Inhibitor (BMS-663068) is effective in the treatment of heavily treatment experienced HIV-1 patients with multi-drug resistance.
Inclusion Criteria:
Exclusion Criteria:
Ciudad Autonoma Buenos Aires, C1405CKC, Argentina
Ciudad Autonoma de Buenos Aire, C1155ADP, Argentina
RibeirAo PretoSP, 14048-900, Brazil
Monza MB, 20900, Italy
Guadajalara, 44280, Mexico
Auckland Park Johannesb, 2092, South Africa
Observatory Cape Town, 7925, South Africa